Question · asked by 1 review
Pegloticase every two weeks (biweekly) vs placebo: Joint pain reduction ‐ not reported
- Population
- participants with tophi in gout
- Intervention
- Pegloticase every two weeks (biweekly)
- Comparison
- placebo
- Outcome
- Joint pain reduction ‐ not reported
The review found no eligible studies for this question.
What each review found
Current versions onlyNo studies found 2 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Pegloticase every two weeks (biweekly) vs placebo Joint pain reduction ‐ not reported · participants with tophi in gout The review found no eligible studies for this question. Interventions for tophi in gout (2021) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Pegloticase every two weeks (biweekly) vs placebo Joint pain reduction ‐ not reported · participants with tophi in gout The review found no eligible studies for this question. Interventions for tophi in gout (2014) · Cochrane Headline outcomes onlyearlier version CD010069.PUB2, superseded | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for tophi in gout 2021 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.